Cargando…

Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care

OBJECTIVE: The Swedish guidelines recommend that patients with chronic obstructive pulmonary disease (COPD) on maintenance treatment are monitored annually, and within six weeks after an exacerbation. We describe the patterns of COPD-related visits in Sweden, both regular follow-up and post-exacerba...

Descripción completa

Detalles Bibliográficos
Autores principales: Sandelowsky, Hanna, Janson, Christer, Wiklund, Fredrik, Telg, Gunilla, de Fine Licht, Sofie, Ställberg, Björn
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375582/
https://www.ncbi.nlm.nih.gov/pubmed/35971390
http://dx.doi.org/10.2147/COPD.S372266
_version_ 1784767995666497536
author Sandelowsky, Hanna
Janson, Christer
Wiklund, Fredrik
Telg, Gunilla
de Fine Licht, Sofie
Ställberg, Björn
author_facet Sandelowsky, Hanna
Janson, Christer
Wiklund, Fredrik
Telg, Gunilla
de Fine Licht, Sofie
Ställberg, Björn
author_sort Sandelowsky, Hanna
collection PubMed
description OBJECTIVE: The Swedish guidelines recommend that patients with chronic obstructive pulmonary disease (COPD) on maintenance treatment are monitored annually, and within six weeks after an exacerbation. We describe the patterns of COPD-related visits in Sweden, both regular follow-up and post-exacerbation visits. METHODS: Patients (>40 years) with a first-time COPD diagnosis between 2006 and 2017 were identified in primary care medical records and linked to hospital contacts and administered drug data. The index date was defined as the first collection of inhaled COPD maintenance treatment after the diagnosis. Regular COPD visits within 15-months after the index, and post-exacerbation visits for COPD within six weeks and 15-months after an exacerbation were estimated using the cumulative incidence function adjusted for competing risk. Visits without a ICD code for COPD were not included in the analyses. RESULTS: A total of 19,857 patients (mean age 69 years, 57% females) were included. The overall probability of having a regular follow-up visit for COPD within 15 months post-index was 39.1%. In total, 15,095 (76%) patients experienced at least one COPD exacerbation during the observation period. Among them, the probability of having a post-exacerbation visit was 7.0% within six weeks and 29.7% within 15-months. Patients without a regular COPD follow-up visit claimed significantly more oral corticosteroids (25.6% vs 15.6%), more respiratory antibiotics (39.1% vs 23.1%), and less maintenance treatment (10.9% vs 16.5%). CONCLUSION: Only 39% of COPD patients attended a regular follow-up visit within 15-months from the COPD diagnosis and one-third had a post-exacerbation visit. The adherence to guideline recommendations need to be improved.
format Online
Article
Text
id pubmed-9375582
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-93755822022-08-14 Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care Sandelowsky, Hanna Janson, Christer Wiklund, Fredrik Telg, Gunilla de Fine Licht, Sofie Ställberg, Björn Int J Chron Obstruct Pulmon Dis Original Research OBJECTIVE: The Swedish guidelines recommend that patients with chronic obstructive pulmonary disease (COPD) on maintenance treatment are monitored annually, and within six weeks after an exacerbation. We describe the patterns of COPD-related visits in Sweden, both regular follow-up and post-exacerbation visits. METHODS: Patients (>40 years) with a first-time COPD diagnosis between 2006 and 2017 were identified in primary care medical records and linked to hospital contacts and administered drug data. The index date was defined as the first collection of inhaled COPD maintenance treatment after the diagnosis. Regular COPD visits within 15-months after the index, and post-exacerbation visits for COPD within six weeks and 15-months after an exacerbation were estimated using the cumulative incidence function adjusted for competing risk. Visits without a ICD code for COPD were not included in the analyses. RESULTS: A total of 19,857 patients (mean age 69 years, 57% females) were included. The overall probability of having a regular follow-up visit for COPD within 15 months post-index was 39.1%. In total, 15,095 (76%) patients experienced at least one COPD exacerbation during the observation period. Among them, the probability of having a post-exacerbation visit was 7.0% within six weeks and 29.7% within 15-months. Patients without a regular COPD follow-up visit claimed significantly more oral corticosteroids (25.6% vs 15.6%), more respiratory antibiotics (39.1% vs 23.1%), and less maintenance treatment (10.9% vs 16.5%). CONCLUSION: Only 39% of COPD patients attended a regular follow-up visit within 15-months from the COPD diagnosis and one-third had a post-exacerbation visit. The adherence to guideline recommendations need to be improved. Dove 2022-08-09 /pmc/articles/PMC9375582/ /pubmed/35971390 http://dx.doi.org/10.2147/COPD.S372266 Text en © 2022 Sandelowsky et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Sandelowsky, Hanna
Janson, Christer
Wiklund, Fredrik
Telg, Gunilla
de Fine Licht, Sofie
Ställberg, Björn
Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title_full Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title_fullStr Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title_full_unstemmed Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title_short Lack of COPD-Related Follow-Up Visits and Pharmacological Treatment in Swedish Primary and Secondary Care
title_sort lack of copd-related follow-up visits and pharmacological treatment in swedish primary and secondary care
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9375582/
https://www.ncbi.nlm.nih.gov/pubmed/35971390
http://dx.doi.org/10.2147/COPD.S372266
work_keys_str_mv AT sandelowskyhanna lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare
AT jansonchrister lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare
AT wiklundfredrik lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare
AT telggunilla lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare
AT definelichtsofie lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare
AT stallbergbjorn lackofcopdrelatedfollowupvisitsandpharmacologicaltreatmentinswedishprimaryandsecondarycare